Search Results - "Christoffer El‐Galaly, Tarec"

Refine Results
  1. 1

    Pre‐treatment total metabolic tumour volumes in lymphoma: Does quantity matter? by ElGalaly, Tarec Christoffer, Villa, Diego, Cheah, Chan Yoon, Gormsen, Lars C.

    Published in British journal of haematology (01-04-2022)
    “…Summary Positron emission tomography/computed tomography (PET/CT) is used for the staging of lymphomas. Clinical information, such as Ann Arbor stage and…”
    Get full text
    Journal Article
  2. 2

    Bone health and glucocorticoid‐containing lymphoma therapy — a review of risk factors and preventative measures by Eyre, Toby A., Jensen, Paw, Booth, Stephen, ElGalaly, Tarec Christoffer

    Published in British journal of haematology (01-08-2022)
    “…With survival outcomes ever improving for patients with a wide range of lymphoma histologies, the focus on reducing long‐term complications of therapy has…”
    Get full text
    Journal Article
  3. 3

    Late relapses in Hodgkin lymphoma – should we search for the needle in the haystack? by ElGalaly, Tarec Christoffer, Glimelius, Ingrid

    Published in British journal of haematology (01-07-2022)
    “…Hodgkin lymphoma is among the most curable cancers. For patients in remission for 24 months, residual lifetime becomes close to that of the background…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Routine imaging for disease surveillance in follicular lymphoma—To comfort the patients or their doctors? by ElGalaly, Tarec Christoffer, Øvlisen, Andreas Kiesbye, Cheah, Chan Yoon

    Published in Cancer (15-09-2021)
    “…The effectiveness and outcomes of routine imaging for disease surveillance in lymphomas have been questioned. In patients with follicular lymphoma, no clinical…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Detecting deviations from the efficacy and safety results of single‐arm trials using real‐world data: The case of a CAR‐T cell therapy in B‐cell lymphoma by Jakobsen, Lasse Hjort, Callréus, Torbjörn, Sessa, Maurizio, Jerkeman, Mats, Andersen, Morten, ElGalaly, Tarec Christoffer

    Published in Pharmacoepidemiology and drug safety (01-04-2021)
    “…Purpose Personalized therapies are leading to an increasing number of marketing authorizations based on single‐arm trials, which increases the demand for…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Primary gastric diffuse large B‐cell lymphoma: A multicentre retrospective study by Lewis, Cameron S., Joy, Greta, Jensen, Paw, Barraclough, Allison, Franco, Nunzio, Talaulikar, Dipti, Hawkes, Eliza A., ElGalaly, Tarec Christoffer, Villa, Diego, Dickinson, Michael, Seymour, John F., Cheah, Chan Y.

    Published in British journal of haematology (01-08-2024)
    “…Summary Primary gastric diffuse large B‐cell lymphoma (PG‐DLBCL) accounts for the majority of extra‐nodal DLBCL. Even so, literature is lacking on early,…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    miR-155 as a Biomarker in B-Cell Malignancies by Dybkær, Karen, Roug, Anne Stidsholt, Johnsen, Hans Erik, Bøgsted, Martin, Schmitz, Alexander, Bødker, Julie Støve, Svendsen, Pernille, Due, Hanne, El-Galaly, Tarec Christoffer

    Published in BioMed research international (01-01-2016)
    “…MicroRNAs have the potential to be useful biomarkers in the development of individualized treatment since they are easy to detect, are relatively stable during…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20